CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Learn Biotech Investing

Comprehensive guides to understanding FDA drug approvals, clinical trials, and biotech catalysts. Essential knowledge for biotech investors.

Weekly Catalyst Digest

Auto-Updated

Get a summary of this week's FDA dates, Phase 3 readouts, and AdCom meetings. Navigate between weeks to plan ahead.

View Digest

Biotech Academy

Structured learning path — earn XP and badges as you learn

Continue Learning

What Is Biotechnology?

0/4

This course is not an official training program. It provides no certification or professional qualification. It does not encourage investing in biotechnology or any securities. This content has no official educational value.

Biotech 101

The fundamentals of biotechnology. What biotech companies do, how drugs are developed, and why catalysts matter.

4 lessons
140 XP

0/4 completed

FDA & Regulation

How the FDA reviews and approves drugs. PDUFA dates, AdCom meetings, NDA/BLA submissions, and special designations.

5 lessons
275 XP

0/5 completed

Clinical Trials Deep Dive

Go deeper into clinical trial design, endpoints, data readouts, and how to interpret results.

5 lessons
275 XP

0/5 completed

Pro
Market Dynamics

How biotech stocks trade around catalysts. Pricing mechanics, institutional behavior, and market structure insights.

4 lessons
80 XP
Pro
Advanced Analysis

Advanced analysis concepts. Competitive landscape assessment, pipeline valuation frameworks, and multi-catalyst analysis.

4 lessons
100 XP
Pro
Gene & Cell Therapy

The science and business of gene therapy, CAR-T, CRISPR, and next-generation cell therapies.

4 lessons
480 XP
Pro
M&A & Partnerships

How biotech acquisitions, licensing deals, and partnerships work — and why they are major stock catalysts.

5 lessons
5100 XP
Pro
IPO & Capital Markets

How biotech companies raise capital through IPOs, secondary offerings, ATMs, and venture funding.

4 lessons
480 XP
Rare Diseases & Orphan Drugs

The unique economics and regulatory advantages of rare disease drug development.

4 lessons
460 XP

0/4 completed

Pro
Oncology Deep Dive

The largest therapeutic area in biotech. Understand immuno-oncology, targeted therapy, endpoints, and market dynamics.

5 lessons
5100 XP
Pro
Patent & IP Strategy

How patents protect biotech assets. Patent cliffs, biosimilar competition, IP litigation, and lifecycle management.

5 lessons
5100 XP
International Markets

Beyond the FDA — how drug approval and market access work in Europe, China, Japan, and other major markets.

4 lessons
460 XP

0/4 completed

Reference Guides

In-depth articles on specific biotech topics

6 GuidesRegulatoryClinicalFinancial

Ready to Track Catalysts?

Put your knowledge into practice with our real-time catalyst calendar.

View Catalyst Calendar